MedPath

Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancer

Phase 2
Conditions
liver metastases of colorectal cancer
Registration Number
JPRN-UMIN000001498
Lead Sponsor
agoya Surgical Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Prior chemotherapy with TS-1 (2) Multiple cancer (3) Severe complication (4) Active diarrhea (5) Prebious history of severe drug-induced allergy (6) Pregnant (7) Disqualified by attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
disease free survival
Secondary Outcome Measures
NameTimeMethod
overall survival, side effect
© Copyright 2025. All Rights Reserved by MedPath